Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

[External radiotherapy or non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement].

Zouhair A, Ozsahin M, Mouhsine E, Leyvraz PF, Mirimanoff RO, Coucke PA.

Schweiz Med Wochenschr. 1999 Mar 6;129(9):370-6. Review. French.

PMID:
10198948
2.
3.

[Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].

Kölbl O, Flentje M, Eulert J, Barthel T, Knelles D, Kraus U.

Strahlenther Onkol. 1997 Dec;173(12):677-82. German.

PMID:
9454352
4.
5.

Heterotopic ossification in patients after total hip replacement.

Stołtny T, Koczy B, Wawrzynek W, Miszczyk L.

Ortop Traumatol Rehabil. 2007 May-Jun;9(3):264-72. Review. English, Polish.

PMID:
17721424
6.

Preoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement results of a prospective study in 462 hips.

Koelbl O, Seufert J, Pohl F, Tauscher A, Lehmann H, Springorum HW, Flentje M.

Strahlenther Onkol. 2003 Nov;179(11):767-73.

PMID:
14605747
7.

Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty.

Pakos EE, Stafilas KS, Tsekeris PG, Politis AN, Mitsionis G, Xenakis TA.

Strahlenther Onkol. 2009 Aug;185(8):500-5. doi: 10.1007/s00066-009-1954-3. Epub 2009 Aug 4.

PMID:
19652932
8.

Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty.

Strauss JB, Chen SS, Shah AP, Coon AB, Dickler A.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1460-4. doi: 10.1016/j.ijrobp.2007.12.006. Epub 2008 Jan 30.

PMID:
18234435
9.

Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis.

Balboni TA, Gobezie R, Mamon HJ.

Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1289-99. Review.

PMID:
16863921
10.

Prevention of heterotopic ossification after total hip replacement with NSAIDs.

Fijn R, Koorevaar RT, Brouwers JR.

Pharm World Sci. 2003 Aug;25(4):138-45. Review.

PMID:
12964491
12.
13.

[Prevention of heterotopic ossification following prosthetic total hip replacement].

Zouhair A, Ozsahin M, Garofalo R, Leyvraz PF, Theumann N, Mirimanoff RO, Coucke PA, Mouhsine E.

Rev Med Suisse Romande. 2004 Sep;124(9):579-82. Review. French.

PMID:
15552755
14.

Pharmacological treatment of heterotopic ossification following hip and acetabular surgery.

Macfarlane RJ, Ng BH, Gamie Z, El Masry MA, Velonis S, Schizas C, Tsiridis E.

Expert Opin Pharmacother. 2008 Apr;9(5):767-86. doi: 10.1517/14656566.9.5.767. Review.

PMID:
18345954
15.

[Radiotherapy as prevention of heterotopic ossification--preliminary results].

Miszczyk L, Spindel J, Maciejewski B, Walichiewicz P, Tarnawski R, Horzela A, Woźniak G.

Przegl Lek. 2004;61(2):61-4. Polish.

PMID:
15230142
16.

The role of radiotherapy for prevention of heterotopic ossification after major hip surgery.

Andreu Martínez FJ, Martínez Mateu JM, Tormo Ferrero V.

Clin Transl Oncol. 2007 Jan;9(1):28-31. Review.

PMID:
17272227
17.

Heterotopic ossification following total hip arthroplasty: a review.

Hu HP, Slooff TJ, van Horn JR.

Acta Orthop Belg. 1991;57(2):169-82. Review.

PMID:
1908171
19.

Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.

van der Heide HJ, Rijnberg WJ, Van Sorge A, Van Kampen A, Schreurs BW.

Acta Orthop. 2007 Feb;78(1):90-4.

PMID:
17453398
20.

Heterotopic bone formation after joint replacement.

Nilsson OS, Persson PE.

Curr Opin Rheumatol. 1999 Mar;11(2):127-31. Review.

PMID:
10319216

Supplemental Content

Support Center